Secondary tauopathies include Alzheimer’s disease and chronic traumatic encephalopathy, where the tau accumulation appears to be secondary to a distinct upstream cause but nevertheless is believed to be an important driver of neurodegeneration. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.